Oncolytics Biotech (ONCY)

Create an Alert
2.45 +0.19  +8.41%   NASDAQ Jun 19, 5:00PM BATS Real time Currency in USD

Oncolytics Biotech Cash and ST Investments:

21.41M for Dec. 31, 2012
View Full Chart

Oncolytics Biotech Cash and ST Investments Chart

    Oncolytics Biotech Historical Cash and ST Investments Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 21.41M
    Sept. 30, 2012 28.53M
    June 30, 2012 34.62M
    March 31, 2012 46.76M
    Dec. 31, 2011 34.16M
    Sept. 30, 2011 40.78M
    June 30, 2011 49.47M
    March 31, 2011 54.94M
    Dec. 31, 2010 42.91M
    Sept. 30, 2010 19.13M
    June 30, 2010 23.61M
    March 31, 2010 28.29M
    Dec. 31, 2009 32.36M
    Sept. 30, 2009 8.908M
    June 30, 2009 10.37M
    March 31, 2009 7.363M
    Dec. 31, 2008 10.95M
    Sept. 30, 2008 12.10M
    June 30, 2008 17.75M
       
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro

    About Cash and Short Term Investments

    Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

    Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
    Learn More

    Get data for

    ONCY Cash and ST Investments Benchmarks

    Companies
    Optimer Pharmaceuticals 124.00M
    Anika Therapeutics 50.97M
    Jazz Pharmaceuticals 450.51M

    ONCY Cash and ST Investments Rankings

    Overall 68th percentile
    5351 of 16782
    Sector 64th percentile
    494 of 1410 in Healthcare
    Industry 60th percentile
    179 of 454 in Biotechnology

    ONCY Cash and ST Investments Range, Past 5 Years

    Minimum 7.363M Mar 2009
    Maximum 54.94M Mar 2011
    Average 27.60M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');